SBH
CVS icon

Segall Bryant & Hamill’s CVS Health CVS Stock Holding History

Segall Bryant & Hamill’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.31M Hold
22,322
– – 0.03% 437
2026
Q1 		$1.6M Hold
22,322
– – 0.02% 441
2025
Q4 		$1.77M Hold
22,322
– – 0.02% 451
2025
Q3 		$1.68M Buy
22,322
+122
+0.5% +$8.36K 0.02% 452
2025
Q2 		$1.53M Sell
22,200
-7,171
-24% -$470K 0.02% 467
2025
Q1 		$1.99M Sell
29,371
-1,270
-4% -$76K 0.03% 429
2024
Q4 		$1.38M Buy
30,641
+1,269
+4% +$71.2K 0.02% 474
2024
Q3 		$1.85M Buy
+29,372
New +$1.71M 0.03% 450
2023
Q4 		– Sell
-18,985
Closed -$1.33M – 346
2023
Q3 		$1.33M Sell
18,985
-491
-3% -$34.8K 0.02% 433
2023
Q2 		$1.35M Sell
19,476
-345
-2% -$24.5K 0.01% 461
2023
Q1 		$1.47M Buy
19,821
+578
+3% +$48.5K 0.02% 455
2022
Q4 		$1.79M Buy
19,243
+40
+0.2% +$3.86K 0.02% 428
2022
Q3 		$1.83M Buy
19,203
+130
+0.7% +$12.9K 0.02% 434
2022
Q2 		$1.77M Buy
19,073
+75
+0.4% +$7.32K 0.02% 440
2022
Q1 		$1.93M Sell
18,998
-1,275
-6% -$134K 0.02% 449
2021
Q4 		$2.1M Buy
20,273
+1,523
+8% +$141K 0.02% 406
2021
Q3 		$1.59M Buy
18,750
+3,247
+21% +$272K 0.02% 486
2021
Q2 		$1.29M Buy
15,503
+854
+6% +$69.9K 0.01% 495
2021
Q1 		$1.1M Sell
14,649
-91
-0.6% -$6.63K 0.01% 540
2020
Q4 		$1.01M Sell
14,740
-788
-5% -$51.3K 0.01% 478
2020
Q3 		$909K Buy
15,528
+3,398
+28% +$211K 0.01% 467
2020
Q2 		$785K Sell
12,130
-61
-0.5% -$3.84K 0.01% 486
2020
Q1 		$728K Buy
12,191
+474
+4% +$31.6K 0.01% 506
2019
Q4 		$870K Sell
11,717
-738
-6% -$51.8K 0.01% 546
2019
Q3 		$788K Sell
12,455
-1,000
-7% -$59.3K 0.01% 559
2019
Q2 		$730K Sell
13,455
-3,341
-20% -$180K 0.01% 597
2019
Q1 		$903K Sell
16,796
-1,483
-8% -$91.5K 0.01% 556
2018
Q4 		$1.2M Buy
18,279
+6,472
+55% +$483K 0.02% 492
2018
Q3 		$929K Sell
11,807
-1,114
-9% -$79.6K 0.01% 560
2018
Q2 		$831K Buy
12,921
+1,935
+18% +$128K 0.01% 573
2018
Q1 		$683K Sell
10,986
-281
-2% -$20.2K 0.02% 393
2017
Q4 		$817K Sell
11,267
-719
-6% -$52.3K 0.02% 365
2017
Q3 		$975K Sell
11,986
-285
-2% -$22.5K 0.02% 359
2017
Q2 		$987K Sell
12,271
-111
-0.9% -$8.77K 0.02% 362
2017
Q1 		$972K Sell
12,382
-925
-7% -$73.8K 0.02% 350
2016
Q4 		$1.05M Buy
13,307
+5
+0% +$405 0.03% 346
2016
Q3 		$1.18M Sell
13,302
-89
-0.7% -$8.4K 0.03% 336
2016
Q2 		$1.28M Hold
13,391
– – 0.03% 331
2016
Q1 		$1.39M Sell
13,391
-530
-4% -$51.5K 0.03% 328
2015
Q4 		$1.36M Sell
13,921
-100
-0.7% -$9.79K 0.03% 323
2015
Q3 		$1.35M Sell
14,021
-82
-0.6% -$8.62K 0.03% 327
2015
Q2 		$1.48M Sell
14,103
-276
-2% -$28.2K 0.03% 328
2015
Q1 		$1.48M Buy
14,379
+800
+6% +$80.9K 0.03% 320
2014
Q4 		$1.31M Sell
13,579
-530
-4% -$46.7K 0.03% 329
2014
Q3 		$1.12M Sell
14,109
-369
-3% -$29.1K 0.03% 343
2014
Q2 		$1.09M Sell
14,478
-1,820
-11% -$138K 0.03% 307
2014
Q1 		$1.22M Sell
16,298
-250
-2% -$17.7K 0.03% 312
2013
Q4 		$1.18M Hold
16,548
– – 0.03% 321
2013
Q3 		$939K Buy
16,548
+2,115
+15% +$126K 0.02% 332
2013
Q2 		$825K Buy
+14,433
New +$836K 0.02% 321

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Segall Bryant & Hamill's CVS Position: Q2 2026 in Review

Segall Bryant & Hamill held its CVS Health (CVS) position steady in Q2 2026 at 22,322 shares worth $2.31M. The position accounts for 0.03% of the portfolio, ranked #437.

Segall Bryant & Hamill first reported a position in CVS in Q2 2013 and has held it in 50 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Segall Bryant & Hamill held 22,322 shares of CVS Health worth $2.31M as of Q2 2026.
  • Segall Bryant & Hamill left its CVS Health share count unchanged in Q2 2026.
  • CVS Health made up 0.03% of Segall Bryant & Hamill's portfolio in Q2 2026, its #437 holding.
  • Segall Bryant & Hamill first reported a position in CVS Health in Q2 2013 and has held it in 50 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.